Dr. Osborne Wong

Dr. Wong carried out his Ph.D. studies in the laboratory of Professor Richard Schowen studying reaction mechanisms.  Following postdoctoral studies at the National Institutes of Health, Dr. Wong returned to Lawrence as Section Leader of Analytical Pharmaceutical Chemistry at Oread Laboratories Inc.  In 1994 he moved to California to join Cygnus Inc. as Director of Analytical Sciences.  He returned to KU in 1997, when he was named the Assistant Director of the Center for BioAnalytical Research.  That same year Dr. Wong was named President of ProQuest Pharmaceuticals Inc. in Lawrence.  During his career, Dr. Wong managed product stability and FDA inspection of the Salmeterol (Serevent®) metered-dose inhalers, helped developed a multi-year program supporting the New Drug Application for Amifostine (Ethyol®), and contributed to the design and development of the initial commercial injectable liquid formulation of Integrilin®.